FDA Inspection 1064555 — Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.
The FDA completed an inspection of Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. on Jul 26, 2018 in Changzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 26, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Changzhou (China)